Literature DB >> 23454057

Interactions of U937 macrophage-like cells with decellularized pericardial matrix materials: influence of crosslinking treatment.

Jonathan K McDade1, Ellen P Brennan-Pierce, Marianne B Ariganello, Rosalind S Labow, J Michael Lee.   

Abstract

While macrophages have been implicated in the failure of bioprosthetic heart valves, the macrophage response to crosslinked native pericardial collagen has not been previously investigated. Using decellularized bovine pericardium (DBP) as a model for native collagen, this study investigated the response of macrophage-like cells (U937s) to DBP, either: (i) untreated, or (ii) exogenously crosslinked with glutaraldehyde or 1-ethyl-3-(3-dimethyl-aminopropyl)-carbodiimide (EDC). We have previously validated the use of U937 cells as models for the response of human monocyte-derived macrophages to decellularized pericardial materials and, per our previous work, differentiated the U937 cells directly on the three material surfaces. After 72h in culture, the cells and medium were analyzed for DNA content, acid phosphatase activity, and cytokine and matrix metalloproteinase release. As well, cell/substrate samples were fixed for SEM. Fewer cells attached to or survived on the glutaraldehyde-treated substrate, and some showed an abnormal morphology compared to cells cultured on the other surfaces. Further, cells on glutaraldehyde-treated surfaces released more pro-inflammatory cytokines, more MMP-1 and less MMP-2 and MMP-9. The poor performance of the U937 macrophage-like cells on the glutaraldehyde-treated surfaces appears to be due to surface characteristics rather than to soluble aldehyde or other components leaching from the crosslinked material. These results provide evidence that crosslinking with glutaraldehyde is cytotoxic to macrophage-like cells, and that crosslinking with a zero-length crosslinker like EDC can be an acceptable alternative crosslinking treatment for biomaterials.
Copyright © 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23454057     DOI: 10.1016/j.actbio.2013.02.021

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  16 in total

1.  Pericardial tissue for cardiovascular application: an in-vitro evaluation of established and advanced production processes.

Authors:  L Grefen; F König; M Grab; C Hagl; N Thierfelder
Journal:  J Mater Sci Mater Med       Date:  2018-11-03       Impact factor: 3.896

2.  To cross-link or not to cross-link? Cross-linking associated foreign body response of collagen-based devices.

Authors:  Luis M Delgado; Yves Bayon; Abhay Pandit; Dimitrios I Zeugolis
Journal:  Tissue Eng Part B Rev       Date:  2015-03-12       Impact factor: 6.389

Review 3.  Extracellular Matrix-Based Strategies for Immunomodulatory Biomaterials Engineering.

Authors:  Andrew T Rowley; Raji R Nagalla; Szu-Wen Wang; Wendy F Liu
Journal:  Adv Healthc Mater       Date:  2019-02-04       Impact factor: 9.933

4.  Tunable Protein Hydrogels: Present State and Emerging Development.

Authors:  J Nie; X Zhang; W Wang; J Ren; A-P Zeng
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

5.  Use of myocardial matrix in a chitosan-based full-thickness heart patch.

Authors:  Seokwon Pok; Omar M Benavides; Patrick Hallal; Jeffrey G Jacot
Journal:  Tissue Eng Part A       Date:  2014-02-24       Impact factor: 3.845

6.  Transdentinal cytotoxicity of glutaraldehyde on odontoblast-like cells.

Authors:  Débora Lopes Salles Scheffel; Diana Gabriela Soares; Fernanda Gonçalves Basso; Carlos Alberto de Souza Costa; David Pashley; Josimeri Hebling
Journal:  J Dent       Date:  2015-05-15       Impact factor: 4.379

Review 7.  Crosstalk Between Cardiac Cells and Macrophages Postmyocardial Infarction: Insights from In Vitro Studies.

Authors:  Pamela Hitscherich; Eun Jung Lee
Journal:  Tissue Eng Part B Rev       Date:  2020-12-03       Impact factor: 7.376

Review 8.  Naturally derived biomaterials for addressing inflammation in tissue regeneration.

Authors:  Rebecca A Hortensius; Brendan Ac Harley
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-04

Review 9.  Rational Design of Immunomodulatory Hydrogels for Chronic Wound Healing.

Authors:  Mahshid Kharaziha; Avijit Baidya; Nasim Annabi
Journal:  Adv Mater       Date:  2021-07-12       Impact factor: 32.086

Review 10.  Antifibrotic therapies to control cardiac fibrosis.

Authors:  Zhaobo Fan; Jianjun Guan
Journal:  Biomater Res       Date:  2016-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.